Berberine hydrochloride: anticancer activity and nanoparticulate delivery system
- PMID: 21931477
- PMCID: PMC3173044
- DOI: 10.2147/IJN.S22683
Berberine hydrochloride: anticancer activity and nanoparticulate delivery system
Abstract
Background: Berberine hydrochloride is a conventional component in Chinese medicine, and is characterized by a diversity of pharmacological effects. However, due to its hydrophobic properties, along with poor stability and bioavailability, the application of berberine hydrochloride was hampered for a long time. In recent years, the pharmaceutical preparation of berberine hydrochloride has improved to achieve good prospects for clinical application, especially for novel nanoparticulate delivery systems. Moreover, anticancer activity and novel mechanisms have been explored, the chance of regulating glucose and lipid metabolism in cancer cells showing more potential than ever. Therefore, it is expected that appropriate pharmaceutical procedures could be applied to the enormous potential for anticancer efficacy, to give some new insights into anticancer drug preparation in Chinese medicine.
Methods and results: We accessed conventional databases, such as PubMed, Scope, and Web of Science, using "berberine hydrochloride", "anti-cancer mechanism", and "nanoparticulate delivery system" as search words, then summarized the progress in research, illustrating the need to explore reprogramming of cancer cell metabolism using nanoparticulate drug delivery systems.
Conclusion: With increasing research on regulation of cancer cell metabolism by berberine hydrochloride and troubleshooting of issues concerning nanoparticulate delivery preparation, berberine hydrochloride is likely to become a natural component of the nanoparticulate delivery systems used for cancer therapy. Meanwhile, the known mechanisms of berberine hydrochloride, such as decreased multidrug resistance and enhanced sensitivity of chemotherapeutic drugs, along with improvement in patient quality of life, could also provide new insights into cancer cell metabolism and nanoparticulate delivery preparation.
Keywords: anticancer mechanisms; berberine hydrochloride; nanoparticulate drug progress.
Figures
Similar articles
-
Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations.J Ethnopharmacol. 2009 Oct 29;126(1):5-17. doi: 10.1016/j.jep.2009.08.009. Epub 2009 Aug 15. J Ethnopharmacol. 2009. PMID: 19686830 Review.
-
[Preparation and in vitro evaluation of self-assembled beads drug delivery system of berberine hydrochloride].Zhongguo Zhong Yao Za Zhi. 2013 Jun;38(12):1924-8. Zhongguo Zhong Yao Za Zhi. 2013. PMID: 24066585 Chinese.
-
Berberine-loaded Janus nanocarriers for magnetic field-enhanced therapy against hepatocellular carcinoma.Chem Biol Drug Des. 2017 Mar;89(3):464-469. doi: 10.1111/cbdd.12866. Epub 2016 Oct 26. Chem Biol Drug Des. 2017. PMID: 27618577
-
Pharmacokinetic behaviors of soft nanoparticulate formulations of chemotherapeutics.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Mar;15(2):e1846. doi: 10.1002/wnan.1846. Epub 2022 Aug 18. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023. PMID: 35979879 Free PMC article. Review.
-
Nanodelivery system of traditional Chinese medicine bioactive compounds: Application in the treatment of prostate cancer.Phytomedicine. 2024 Dec;135:155554. doi: 10.1016/j.phymed.2024.155554. Epub 2024 Mar 29. Phytomedicine. 2024. PMID: 39341127 Review.
Cited by
-
Biophysical characterization of the strong stabilization of the RNA triplex poly(U)•poly(A)*poly(U) by 9-O-(ω-amino) alkyl ether berberine analogs.PLoS One. 2012;7(5):e37939. doi: 10.1371/journal.pone.0037939. Epub 2012 May 29. PLoS One. 2012. PMID: 22666416 Free PMC article.
-
Self-Nanoemulsifying Drug Delivery System of Tetrandrine for Improved Bioavailability: Physicochemical Characterization and Pharmacokinetic Study.Biomed Res Int. 2018 Sep 27;2018:6763057. doi: 10.1155/2018/6763057. eCollection 2018. Biomed Res Int. 2018. PMID: 30363745 Free PMC article.
-
Multiple effects of berberine derivatives on colon cancer cells.Biomed Res Int. 2014;2014:924585. doi: 10.1155/2014/924585. Epub 2014 Jun 18. Biomed Res Int. 2014. PMID: 25045712 Free PMC article.
-
Development and evaluation of berberine-loaded bigel for the treatment of hyperpigmentation on B16F10 melanoma cell line.Nanomedicine (Lond). 2024;19(18-20):1659-1673. doi: 10.1080/17435889.2024.2370759. Epub 2024 Jul 26. Nanomedicine (Lond). 2024. PMID: 39056145 Free PMC article.
-
From prejudice to evidence: the case of rhizoma coptidis in singapore.Evid Based Complement Alternat Med. 2014;2014:871720. doi: 10.1155/2014/871720. Epub 2014 Dec 25. Evid Based Complement Alternat Med. 2014. PMID: 25610485 Free PMC article. Review.
References
-
- Lee IA, Hyun YJ, Kim DH. Berberine ameliorates TNBS-induced colitis by inhibiting lipid peroxidation, enterobacterial growth and NF-kappaB activation. Eur J Pharmacol. 2010;648(1–3):162–170. - PubMed
-
- Liu X, Li G, Zhu H, et al. Beneficial effect of berberine on hepatic insulin resistance in diabetic hamsters possibly involves in SREBPs, LXRalpha and PPARalpha transcriptional programs. Endocr J. 2010;57(10):881–893. - PubMed
-
- Zhou J, Zhou S. Berberine regulates peroxisome proliferator-activated receptors and positive transcription elongation factor b expression in diabetic adipocytes. Eur J Pharmacol. 2010;649(1–3):390–397. - PubMed
-
- Wu M, Wang J, Liu LT. Advance of studies on anti-atherosclerosis mechanism of berberine. Chin J Integr Med. 2010;16(2):188–192. - PubMed
-
- Zhao L, Li W, Han F, et al. Berberine reduces insulin resistance induced by dexamethasone in theca cells in vitro. Fertil Steril. 2011;95(1):461–463. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources